CAS 90729-42-3
:Carebastin
- 2-(4-(4-(4-(Benzhydryloxy)piperidin-1-yl)-butanoyl)phenyl)-2-methylpropanoic acid
- 2-(4-(4-(4-Benzhydryloxypiperidino)butyryl)phenyl)-2-methylpropionsaeure
- 2-(4-{4-[4-(Diphenylmethoxy)Piperidin-1-Yl]Butanoyl}Phenyl)-2-Methylpropanoic Acid
- 4-[4-[4-(Diphenylmethoxy)-1-piperidinyl]-1-oxobutyl]-α,α-dimethylbenzeneacetic acid
- Benzeneacetic acid, 4-(4-(4-(diphenylmethoxy)-1-piperidinyl)-1-oxobutyl)-alpha,alpha-dimethyl-
- Benzeneacetic acid, 4-[4-[4-(diphenylmethoxy)-1-piperidinyl]-1-oxobutyl]-α,α-dimethyl-
- Carebastina
- Carebastina [Spanish]
- Carebastine [INN]
- Carebastinum
- Carebastinum [Latin]
- Unii-75Dln707Do
- p-(4-(4-(Diphenylmethoxy)piperidino)butyryl)-alpha-methylhydratropic acid
- Weitere Synonyme anzeigen
Carebastine
CAS:Carebastine, the active metabolite of Ebastine, is an antagonist of the histamine H1 receptor.Formel:C32H37NO4Reinheit:99.16%Farbe und Form:Off-White SolidMolekulargewicht:499.64Carebastine
CAS:CarebastineFormel:C32H37NO4Reinheit:95%Farbe und Form: white solidMolekulargewicht:499.65g/molCarebastine
CAS:Kontrolliertes ProduktApplications The active carboxylic acid metabolite of Ebastine.
References Hashizume, T., et al.: Drug Metab. Dispos., 29, 798 (2001), Hashizume, T., et al.: J. Pharmacol. Exp. Ther., 300, 298 (2002), Matsumoto, S., et al.: Xenobiotica, 33, 615 (2003), Chaikin, P., et al.: Br. J. Clin. Pharmacol., 59, 346 (2005),Formel:C32H37NO4Farbe und Form:NeatMolekulargewicht:499.64Carebastine
CAS:Carebastine is a histamine H1 receptor antagonist. Carebastine blocks the action of histamine on cells that release inflammatory substances and is used to treat allergic symptoms such as itching, sneezing, and runny nose. Carebastine has been shown to reduce the frequency of bowel movements in patients with chronic idiopathic constipation. This drug can also cause side effects such as drowsiness, dry mouth, headache, blurred vision, muscle weakness and pain.
Formel:C32H37NO4Reinheit:Min. 95%Molekulargewicht:499.64 g/mol






